I know the headline sounds like bad clickbait, but there’s an anti-obesity medication that’s disrupting the industry. According to a recent article from The New York Times, the drug is so effective that obese patients who take it could also prevent other consequences such as diabetes. The drug is semaglutide from Novo Nordisk, and it’s already marketed as a treatment for Type 2 diabetes.
Is This Drug the Future of Weight Loss?
A drug marketed for Type 2 diabetes could change the way we treat obesity in the future.
Feb 17, 2021
Break out of the ordinary: see what’s new in life sciences packaging
<strong>At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.</strong>
REGISTER NOW & SAVE!
Researched List: Blister Machines for Life Sciences
Need a blister machine for life sciences packaging? Our curated list features companies serving pharmaceutical, medical device, nutraceutical, and cosmetic industries. Download to access company names, locations, machine specifications, descriptions, and more.
Download Now